(2010). AE: Computed tomography in acute ischemic stroke. Neuroradiology
(2002). Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation
(2010). CH: Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. Clin Neuropharmacol
(2009). CH: The value of leukocyte adhesion molecules in patients after ischemic stroke.
(2007). Clinical practice. Acute ischemic stroke.
(2006). Course of platelet activation and plateletleukocyte interaction in cerebrovascular ischemia. Stroke
(1988). Discovery, biochemistry and biology of lovastatin.
(1993). EE: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial.
(2000). Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res
(2002). F: Time-dependent effect of statins on platelet function in hypercholesterolaemia.
(2005). French WJ: Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
(2002). Grau AJ: Course of platelet activation markers after ischemic stroke. Stroke
(2003). JW: Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis
(2007). KM: Effects of intense lowdensity lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke
(2007). Koroshetz WJ: Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med
(2004). Lalouschek W: Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.
(2005). Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis
(2004). Martí-Vilalta J-L: Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke
(2002). Platelets in atherothrombosis.
(1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
(2008). RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
(2005). Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Arterioscler Thromb Vasc Biol
(2002). Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res
(2005). Secondary prevention of recurrent stroke. Stroke
(2007). Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology
(2002). Statins as potent antiinflammatory drugs. Circulation
(2001). Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol
(2002). Statins: the new aspirin? Cell Mol Life Sci
(2006). Tamargo RJ: Inflammation in stroke and focal cerebral ischemia. Surg Neurol
(2009). Tanne D: Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke
(2003). Withdrawal of statin treatment abrogates stroke protection in mice. Stroke
(2006). Yang JQ: Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Med Hypotheses